Study guide

12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants

APMLE Part I Basic Sciences Podiatry

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Lower Extremity Osteology

1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics

2 Chapter 2: Lower Extremity Arthrology & Ligaments

2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics

3 Chapter 3: Lower Extremity Myology & Compartments

3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations

4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy

4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces

5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods

5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines

6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology

6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods

7 Chapter 7: General & Cellular Pathology

7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors

8 Chapter 8: Systemic & Podiatric Pathology

8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation

9 Chapter 9: Organ-System Pathology

9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology

10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology

10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology

11 Chapter 11: Antimicrobial & Podiatric Therapeutics

11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology

12 Chapter 12: Systemic Pharmacology

12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents

13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy

13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways

14 Chapter 14: Histology, Integument, Embryology & Genetics

14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging

15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology

15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics

16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood

16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology

17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling

17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction

18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition

18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals

12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants

Key Takeaways Explain This Topic AI

Gabapentin and pregabalin bind the alpha-2-delta subunit of voltage-gated calcium channels, need renal dose adjustment and add respiratory depression when combined with opioids.

Duloxetine (an SNRI), pregabalin, tricyclic antidepressants and sodium channel blockers are initial drug options for painful diabetic peripheral neuropathy; duloxetine, pregabalin, tapentadol ER and the capsaicin 8% patch carry FDA approval for it.

Phenytoin shows zero-order kinetics, induces CYP450 and causes gingival hyperplasia; carbamazepine causes hyponatremia and agranulocytosis and is first-line for trigeminal neuralgia; valproate causes neural tube defects.

Serotonin syndrome (clonus, hyperreflexia, hyperthermia) can follow SSRIs or SNRIs combined with tramadol, linezolid, methylene blue or MAO inhibitors; neuroleptic malignant syndrome causes lead-pipe rigidity and develops more slowly.

Tizanidine is contraindicated with ciprofloxacin or fluvoxamine (CYP1A2 inhibition causes severe hypotension), and abrupt baclofen withdrawal can cause seizures and hyperthermia.

Last updated: October 2026

12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants

The Part I outline lists central nervous system and autonomic agents : anticonvulsants, psychotropic agents, skeletal muscle relaxants, neuromuscular blocking agents and antidepressants. Autonomic drugs and neuromuscular blockers are covered in 10.2 and 10.3. These drugs matter in podiatry because several treat painful diabetic peripheral neuropathy , and many interact with the antibiotics, NSAIDs and opioids podiatric clinicians prescribe.

Anticonvulsants

Drug Mechanism High-yield adverse effects and interactions

Phenytoin Blocks voltage-gated Na+ channels (inactivated state) Zero-order kinetics at therapeutic levels; gingival hyperplasia, hirsutism, nystagmus, ataxia; CYP450 inducer ; fetal hydantoin syndrome; SJS/TEN (HLA-B*15:02); purple glove syndrome with IV extravasation

Carbamazepine Na+ channel blocker First-line for trigeminal neuralgia ; agranulocytosis and aplastic anemia, hyponatremia (SIADH) , autoinduction of its own metabolism, CYP inducer, HLA-B*15:02 SJS, neural tube defects

Valproate Na+ channel block, increased GABA, T-type Ca2+ block Hepatotoxicity, pancreatitis, tremor, weight gain, neural tube defects , CYP inhibitor (raises lamotrigine)

  • Lamotrigine Na+ channel blocker Life-threatening rash (SJS/TEN) ; requires slow titration
  • Levetiracetam Binds synaptic vesicle protein SV2A Irritability and mood changes; few drug interactions

Topiramate Na+ block, GABA enhancement, carbonic anhydrase inhibition Kidney stones, weight loss, cognitive slowing

Gabapentin and pregabalin Bind the alpha-2-delta subunit of voltage-gated Ca2+ channels, reducing excitatory transmitter release Sedation, dizziness, peripheral edema , weight gain; renally cleared , so dose reduction is needed in CKD; misuse potential; additive respiratory depression with opioids

Benzodiazepines Increase the frequency of GABA-A chloride channel opening Status epilepticus first-line (lorazepam); dependence; reversal with flumazenil

Antidepressants

Class Examples Key points

SSRIs Sertraline, fluoxetine, citalopram, escitalopram Sexual dysfunction, hyponatremia; bleeding risk with NSAIDs (platelet serotonin depletion); citalopram QT prolongation

SNRIs Duloxetine , venlafaxine Duloxetine is FDA-approved for painful diabetic peripheral neuropathy ; avoid in heavy alcohol use or hepatic disease; venlafaxine can raise blood pressure

Tricyclic antidepressants Amitriptyline, nortriptyline Used at low doses for neuropathic pain; anticholinergic effects, orthostasis, sedation; overdose causes wide-QRS arrhythmias treated with sodium bicarbonate ; avoid in older adults

MAO inhibitors Phenelzine, tranylcypromine, selegiline Tyramine hypertensive crisis ; serotonin syndrome with meperidine, tramadol, linezolid and SSRIs

Atypical agents Bupropion, mirtazapine, trazodone Bupropion lowers the seizure threshold; mirtazapine causes sedation and weight gain; trazodone can cause priapism

Serotonin Syndrome versus Neuroleptic Malignant Syndrome

Feature Serotonin syndrome Neuroleptic malignant syndrome

Triggers Serotonergic combinations (SSRI or SNRI plus tramadol, linezolid, methylene blue, MAO inhibitors, triptans) Dopamine antagonists (antipsychotics, metoclopramide)

  • Onset Hours (usually within 24 hours) Days
  • Neuromuscular signs Clonus, hyperreflexia, tremor Lead-pipe rigidity, bradyreflexia
  • Treatment Stop the drugs, supportive care, cyproheptadine Stop the drug, cooling, dantrolene or bromocriptine
  • Antipsychotics & Other Psychotropic Agents

First-generation (typical) antipsychotics such as haloperidol block D2 receptors strongly. They cause extrapyramidal effects : acute dystonia, akathisia, parkinsonism and tardive dyskinesia.

Second-generation (atypical) antipsychotics such as risperidone, olanzapine, quetiapine and aripiprazole cause metabolic syndrome (weight gain, hyperglycemia, dyslipidemia) and QT prolongation. Clozapine can cause agranulocytosis and requires blood count monitoring.

Lithium has a narrow therapeutic index. NSAIDs, thiazides and ACE inhibitors raise lithium levels (10.5). It causes tremor, hypothyroidism, nephrogenic diabetes insipidus and Ebstein anomaly.

Anxiolytics and sedatives: benzodiazepines and the "Z-drugs" (zolpidem) cause falls and confusion in older adults and are additive with opioids.

Pharmacologic Treatment of Painful Diabetic Peripheral Neuropathy

Diabetes care guidelines list gabapentinoids, SNRIs, tricyclic antidepressants and sodium channel blockers as initial pharmacologic options, chosen by comorbidities and adverse effect profile. FDA-approved agents for this indication include duloxetine, pregabalin, tapentadol extended-release and the capsaicin 8% topical patch . Opioids are not recommended as first-line therapy. Glycemic control, foot protection and treating contributing deficiencies (for example vitamin B12 deficiency from metformin, 9.1) remain essential.

Skeletal Muscle Relaxants & Spasticity Agents

Drug Mechanism Key cautions

Baclofen GABA-B agonist in the spinal cord Sedation; abrupt withdrawal (especially intrathecal) causes seizures, hyperthermia and rebound spasticity

Tizanidine Central alpha-2 agonist Hypotension, hepatotoxicity; contraindicated with ciprofloxacin or fluvoxamine (CYP1A2 inhibition)

Cyclobenzaprine Structurally related to tricyclics; brainstem action Anticholinergic effects; serotonin syndrome risk with SSRIs and tramadol

  • Methocarbamol Central depressant Sedation
  • Carisoprodol Metabolized to meprobamate Misuse and dependence (controlled substance)

Dantrolene Blocks RyR1 calcium release in skeletal muscle Hepatotoxicity with chronic use; antidote for malignant hyperthermia

Botulinum toxin A Cleaves SNAP-25, blocking acetylcholine release Injected into the gastrocnemius-soleus for spastic equinus in cerebral palsy or after stroke

Neuromuscular blocking agents (succinylcholine, rocuronium, vecuronium, cisatracurium) act at the motor endplate nicotinic receptor and are reviewed in 10.2.

Important

Combining gabapentinoids, benzodiazepines, muscle relaxants or sedating antihistamines with opioids compounds respiratory depression and fall risk, especially after foot surgery when patients use crutches or knee scooters.